ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions Inc. (NYSE:EBS), a biopharmaceutical company, announced today that it has signed a $30 million loan agreement with HSBC Realty Credit Corporation (USA) (HSBC). The Company expects to use these funds primarily for its manufacturing expansion in Lansing, Michigan. This loan replaces a prior loan arrangement with HSBC under which HSBC agreed to loan the company $15 million, consisting of a $10 million term loan and a $5 million revolving line of credit.
